Content Library

PROTECTING YOUR SCIENCE FOR LIFE SCIENCE
MANUFACTURING ORGANIZATIONS
Whitepaper from XiltriX

PharmaManufacturing Magazine
Beyond the Surface

Exclusive Fireside Chat with Jon Herlocker

Exclusive Interview with our Chair Mark McCord-Amasis from Seattle Genetics

Annotation 2020-02-17 122813

"The Pharma sector is entering a very exciting time and flection point. The promise of cell and gene therapies (C&GT) is creating a whole host of new biotech focused on delivering these novel medicines to patients. Artificial intelligence and machine learning approaches are raising expectations that R&D may not only be more innovative, but also more time/cost-effective. The challenge for asset management will be to…"